WearLinq
PrivateLast Round
Debt
Dec 17, 2025
Total Funding Raised
$17.3M
Momentum Score
25 /100
Company Overview
WearLinq is a provider of digital healthcare and wearable health monitoring solutions, focusing on ambulatory electrocardiogram (ECG) monitoring. The company has developed the eWave, an FDA 510(k) cleared 6-lead wearable ECG monitor designed for long-term cardiac monitoring. The device, which is lightweight and rechargeable, works with a patient's smartphone and a cloud platform to provide near real-time data and analysis to healthcare providers. In May 2024, WearLinq acquired AMI Cardiac Monitoring, an independent diagnostic testing facility (IDTF), to expand its clinical services across the United States. The company aims to improve the detection of heart rhythm disorders like atrial fibrillation and enhance patient care through its advanced technology.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Healthcare Analytics, Health IoT
Business Model
B2B
Customer Profile
Services & Consulting, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WearLinq Comps
Public and private peers based on sector, stage, and business model.
WearLinq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Dec 17, 2025 | ||||
| Series A | Apr 29, 2025 | ||||
| Seed | Oct 26, 2024 | ||||
| VC Round | May 21, 2024 |
WearLinq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Celtic House Asia Partners Health | Debt |
| AngelSchool.vc | Debt |
| Device of Tomorrow Capital | Debt |
| Smartlink Partners | Debt, Seed |
| Social Impact Capital | VC Round |
| Amino Capital | Debt, VC Round |
| Berkeley Catalyst Fund | Debt, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
Real-time, six-lead EKG product receives FDA clearance.
- Jan 1, 2026
Real-time, six-lead EKG product receives FDA clearance.
WearLinq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WearLinq's valuation, stock price, and market status.
